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Abstraet--[3H]MK-801 binding in rat brain was characterized using a quantitative autoradiographic 
binding assay. [3H]MK-801 binding (5 nM) reached equilibrium by 120 min at 23°C. [3H]MK-801 appeared 
to label a single high affinity site with an affinity constant of approximately 11 nM. [3H]MK-801 binding 
was heterogeneously distributed throughout the brain with the following order of binding densities: 
hippocampal formation > cortical areas > striatum > thalamus. 
Competitive N-methyl-D-aspartate antagonists, Dt:2-amino-5-phosphonopentanoic acid, DL-2-amino- 
7-phosphonoheptanoic acid, 3-(2-carboxypiperazin-4-yl)propyl-l-phosphonic acid, and eis-4-phosphono- 
methyl-2-piperidine carboxylic acid, inhibited [3H]MK-801 binding. Glycine antagonists, 7-chiorokynurenic 
acid and kynurenic acid, also inhibited [3H]MK-801 binding. Furthermore, the inhibition of [3H]MK-801 
binding by the quinoxalinedione compounds 6-cyano-7-nitroquinoxaline-2,3-dione and 6,7-dinitroquin- 
oxaline-2,3-dione was reversed by glycine. [3H]MK-801 binding was also inhibited by zinc ions. [3H]MK-801 
binding was enhanced by glycine or N-methyl-t)-aspartate. 
These results demonstrate that [3H]MK-801 can be used in a quantitative autoradiographic assay as a 
functional probe for the N-methyl-o-aspartate receptor complex. 
Glutamate is a major excitatory amino acid neuro- 
transmitter mediating neuronal signalling within the 
mammalian central nervous system. Glutamate inter- 
acts with at least three receptors which have been 
classified on the basis of agonists that selectively 
activate them: quisqualate, kainate and N-methyl-D- 
aspartate (NMDA))  3'36'6° The N M D A  receptor is the 
best characterized of the receptor subtypes due to the 
availability of selective antagonists. 36 Activation of 
N M D A  receptors has been implicated in a number 
of  physiological and pathological processes includ- 
ing long-term potentiation, learning and memory, 
hypoxic-ischemic neuronal damage, and chronic 
neural degeneration. 8,47 
The N M D A  receptor is associated with a cation 
channel that is gated by magnesium in a voltage- 
dependent fashion. *°,~ The receptor-ion channel 
complex is modulated by several regulatory sites. 
Glycine, acting at a strychnine-insensitive site, increases 
§To whom correspondence should be addressed. 
Abbreviations: AMPA, [RS]<t-amino-3-hydroxy-5-methyl-4- 
isoxazolepropionic acid; AP5, DL-2-amino-5-phosphono- 
pentanoic acid; AP7, DL-2-amino-7-phosphonoheptanoic 
acid; CGS 19755, c/s-4-phosphonomethyl-2-piperidine 
carboxylic acid; CNQX, 6-cyano-7-nitroquinoxaline-2,3- 
dione; CPP, 3-(2-carboxypiperazin-4-yl)propyl-l-phos- 
phonic acid; DNQX, 6,7-dinitro-quinoxaline-2,3-dione; 
HA-966, 3-amino-l-hydroxypyrrolide-2-one; MK-801, 
( + )-5-methyl- 10,11 -dihydro-5H-dibenzo[a,d]cyclohepten- 
5,10-imine maleate; NMDA, N-methyI-D-aspartate; 
PCP, phencyclidine; (+)PPP, (+)-3-(3-hydroxyphenyl)- 
N-(1-propyl)piperidine; SMDG, stratum moleculare of 
the dentate gyrus; SR-CAI, stratum radiatum of CAI; 
TCP, N-(1-[2-thienyl]cyclohexyl)3,4-piperidine. 
NMDA receptor activation. 25 3-(2-Carboxypiperazin- 
4-yl)propyi-l-phosphonic acid (CPP) and cis-4- 
phosphonomethyi-2-piperidine carboxylic acid (CGS 
19755) act as competitive antagonists at the N M D A  
recogni t ion  site. 19'32,37'3s Dissociative anesthetics such 
as ketamine, phencyclidine (PCP) and the novel drug, 
( + ) -  5-methyl- 10,11-dihydro- 5H- dibenzo[a,d]cyclo- 
hepten-5,10-imine maleate (MK-801 or dizocilipine 
maleate), are non-competitive antagonists of the 
N M D A  receptor. 2'21'55 Electrophysiological and bio- 
chemical studies indicate that these drugs act by 
interacting with a so-called PCP receptor within the 
ion channel as potent non-competitive antagonists 
of N M D A  receptors. 42,44,45,55,57 Although autoradio- 
graphic binding studies with [3H]MK-801 have been 
reported, these studies have not assessed the kinetics, 
pharmacology or regional effects of giycine, giutamate 
and other modulators on the binding of [3H]MK-801 
to tissue sections. 4,5 We have characterized in detail a 
quantitative autoradiographic binding assay for the 
PCP receptor using [3H]MK-801 in rat brain. 
EXPERIMENTAL PROCEDURES 
[3H]MK-801 binding assay 
Male Sprague--Dawley rats (175-250g, Charles River) 
were decapitated, the brains rapidly removed and mounted 
on microtome chucks in Lipshaw embedding matrix and 
frozen under powdered dry ice. Twenty-micrometer hori- 
zontal sections were cut on a Lipshaw cryostat and thaw- 
mounted onto gelatin-coated slides. Tissue sections were 
used immediately or stored at -20°C for less than 24 h. 
[3H]MK-801 binding was not altered in tissue sections that 
were stored frozen. Sections were prewashed for 30 min in 
50 mM Tris-acetate buffer (pH 7.4) at 4°C and blown dry 
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under a stream of room temperature air before performing 
the [3H]MK-801 binding assay. In all [3H]MK-801 binding 
experiments, triplicate tissue sections were incubated in 
50 mM Tris-acetate buffer (pH 7.4 at room temperature) 
containing 5-20 nM [3H]MK-801 at a final volume of 10 ml. 
Under these conditions less than 5% of total ligand was 
bound and "zone A" conditions 2a (10% or less of total 
ligand in the incubation mixture is bound) are maintained. 
In order to assess the effects of temperature on the assay, 
[3H]MK-801 binding was performed at 4°C, 23°C and 37°C. 
Optimal pH conditions were determined by varying the pH 
of the 50 mM Tris-acetate buffer in the incubation mixture 
between pH 5.0 and 9.0. 
For regional distribution studies, tissue sections were 
incubated for 120 min in 50 mM Tris-acetate buffer (pH 7.4) 
containing 5 nM [3H]MK-801 at room temperature. Non- 
specific binding was determined in the presence of 5 #M 
unlabeled MK-801. Following the incubation, sections were 
dipped quickly into 50 mM Tris-acetate buffer (pH 7.4 at 
4°C), then rinsed for 80 min in 250 ml of cold buffer and 
blown dry under warm air. In kinetic studies of the associ- 
ation rate, sections were incubated in 50 mM Tris acetate 
buffer (pH 7.4, room temperature) containing 5 nM [3H]MK- 
801 for 11 time points between 2 and 360 min and were then 
rinsed for 80 min in cold buffer. For determination of the 
dissociation rate, sections were first incubated in 50 mM Tris- 
acetate buffer (pH 7.4, room temperature) containing 5 nM 
[3H]MK-801 for 120 rain and were then dipped quickly in 
buffer and placed in a large volume of buffer ("infinite 
dilution") for nine time points between 0 and 360 min at 
room temperature. In saturation studies, for the lower 
concentrations, sections were incubated for 120 min at room 
temperature in 50 mM Tris-acetate buffer containing concen- 
trations of [3H]MK-801 ranging from 1 to 20 nM. For the 
higher concentrations, sections were incubated for 120 min 
in 20nM [3H]MK-801 diluted with unlabeled MK-801 
ranging from 20 to 300 nM. Non-specific binding was deter- 
mined for each point in the presence of 20 #M MK-801. 
In competition studies, unlabeled drugs were included in 
the incubation mixture. In separate experiments, tissue 
sections were prewashed for 30 rain in 50 mM Tris-acetate 
buffer at 37°C (pH 7.4) and [3H]MK-801 binding performed 
in the presence of NMDA (100/aM) or glycine (100 nM or 
100#M) added to the incubation mixture. 
Dried sections were placed in X-ray cassettes with appro- 
priate radioactive standards and apposed to either LKB 
Ultrofilm 3H or Amersham Hyperfilm. Following a 3-4 week 
exposure at 4°C, films were developed in D-19 (Kodak), fixed 
and dried. All data presented were analysed from resultant 
autoradiographic images. Ten to twenty readings per area 
from triplicate sections were analysed using computer-assisted 
image analysis (Imaging Research, Inc., St Catherine's, 
Ontario). Data from kinetic studies were analysed using the 
non-linear regression program LIGAND) 6a Ics0 values for 
competitors were calculated by log-logit analysis and K, 
values were determined by the method of Cheng and 
Prusoff 5" using the formula K, = I%0/(1 + ([L]/Kd)). 
Materials 
[3H]MK-801 (29.4 Ci/mmol) was obtained from Dupont 
New England Nuclear (Boston, MA). Unlabeled MK-801 
was a gift from Dr L. L. Iversen, Merck, Sharpe & Dohme 
Research Laboratories (Essex, U.K.). N-(1-[2-Thienyl]cycio- 
hexyl)3,4-piperidine (TCP) and (+)-3-(3-hydroxypbenyl)-N- 
(1-propyl)piperidine [(+)PPP] were gifts from Dr J. Woods, 
University of Michigan (Ann Arbor, MI). [RS]-ct-Amino-3- 
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and 
CPP were purchased from Research Biocbemicals (Natick, 
MA). CGS 19755 was a gift from Dr R. A. Lovell, Ciba- 
Geigy Corporation (Summit, NJ). Tetrahydroaminoacridine 
was purchased from Aldrich Chemicals (Milwaukee, WI). 
3-Amino- l-hydroxypyrrolide-2-one (HA-966), 7-chlorokyn- 
urenic acid, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 
6,7-dinitro-quinoxaline-2,3-dione (DNQX), DL-2-amino-5- 
phosphonopentanoic acid (AP5), and DL-2-amino-7-phos- 
phonoheptanoic acid (AP7) were obtained from Tocris 
Neuramin (Essex, UK.). All other chemicals were purchased 
from Sigma (St Louis, MO)+ 
RESULTS 
Characterization o f  [3H]MK-801 binding 
In initial experiments, [3H]MK-801 binding per- 
formed at 4°C, 23°C and 37°C indicated that the 
optimal incubation temperature was 23°C, At  4°C 
and 37°C, [3H]MK-801 binding in stratum radiatum 
of the CA1 (SR-CA1) was reduced by 64% and 17%, 
respectively, compared to sections incubated at 2T'C. 
Varying the Tris-acetate incubation buffer over a 
range of  pH values from pH 5.0 to 9.0 revealed 
optimal [3H]MK-801 binding at pH 7.4. At the lower 
pH range between 5.0 and 6.8 and pHs greater than 
8.0, [3H]MK-801 binding was reduced: In preliminar 3, 
experiments, equilibrium was reached at 120 min at 
23°C and the optimal rinse time was 80 rain. At shorter 
rinse times specific binding was reduced slightly. These 
incubation and rinse times were used in subsequent 
saturation, pharmacological and regional distribution 
studies. Under  these conditions, specific binding 
(total binding minus binding in the presence of  5#M 
MK-801) represented 95% of total binding. 
Scatchard analyses of  the saturation isotherms 
revealed that [3H]MK-801 labeled an apparent single 
high affinity site. The maximal binding (Bmax) of  
[3I-I]MK-801 in layers I and II of  frontal cortex was 
2.53 + 0.14 pmol /mg protein and the affinity (Kd) was 
11.6-I-0.5 nM (Fig. 1). Bma x and similar Kd values 
were obtained for SR-CA 1 and stratum moleculare of  
the dentate gyrus (SMDG).  In SR-CA1, the Kd for 
[3H]MK-801 binding was 14.3 ___ 0.9 nM and the Bma x 
was 4.0 ___ 0.2 pmol /mg protein, while in the S M D G  
the K d was 13.4 + 1.4 nM and Bn~x was 3.1 + 0.2 nM. 
In 5 0 m M  Tris-acetate buffer 5 n M  [3H]MK-801 
binding reached equilibrium by 120 min at 23°C and 
remained at equilibrium until at least 360 rain (Fig. 2). 
Specific binding (total binding minus binding in the 
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Fig. 1. Representative Scatchard plot of [3H]MK-80t bind- 
ing in layers I and II of frontal cortex. Rat brain sections 
were incubated in 1-20nM [ 3 ~ + 8 0 1  and unlabeled 
MK-801 (20-300 nM) for 2 h at 25°C. Each point represents 
average specific binding in three sections (total binding 
minus binding in the presence o f  20/~M MK-801). The data 
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Table 1. Inhibition of [3H]MK-801 binding to rat brain 
sections by various compounds 
Fig. 2. Time-course of association and dissociation of 
[3H]MK-801 binding to layers I and II of frontal cortex. 
In association studies, rat brain sections were incubated in 
5 nM [3H]MK-801 for time points indicated on the abscissa 
at 25°C and then rinsed for 80 min in 50 mM Tris-acetate 
buffer. In separate dissociation studies, sections were 
incubated in 5nM [3H]MK-801 for 2h and dissociation 
started by placing sections into a large volume of 50 mM 
Tris-acetate buffer ("infinite dilution") for time points up to 
6 h. Data represent mean specific binding _ S.E.M. of three 
animals. The data are representative of three separate 
experiments. 
presence of 5 ttM MK-801) represented 95% of the 
total binding. The rate constants, k+] and k i were 
calculated from association and dissociation data. 
The association and dissociation curves fit a single 
site kinetic model. The kinetically derived dissociation 
constant (Ka) for the frontal cortex layers I and II was 
0.958 _+ 0.21 nM (mean + S.E.M.). Similar Kd values 
were observed in other regions. In SR-CA1 the Kd for 
[3H]MK-801 binding was 0.79 _+ 0.25 nM while in the 
SMDG the Kd was 0.49 + 0.08 nM. 
Pharmacological profile of [3H]MK-801 binding 
[3H]MK-801 binding was displaced by unlabeled 
MK-801 in a monophasic manner. In SR-CA1 
MK-801 displaced [3H]MK-801 binding with a K~ of 
7.3 _+ 0.8 nM (mean _+ S.E.M.) and a Hill coefficient 
(nil) of 0.98 + 0.06 (Fig. 3). In addition, TCP dis- 
placed [3H]MK-801 binding in SR-CA1 with a K~ of 
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Fig. 3. Inhibition of [3H]MK-80I binding by TCP and MK- 
801 in stratum radiatum of the CAI region of hippocampus. 
Rat brain sections were incubated in 5 nM [3H]MK-801 
either in the presence of varying concentrations of TCP or 
MK-801. Each point represents mean specific binding _.+ 
S.E.M. of three animals. The data are representative of three 
separate experiments. 
Compound K~ n H n 
MK-801 7.3 + 0.8 nM 0.98 __+ 0.06 3 
TCP 55 + 1.8 nM 0.85 + 0.02 3 
CPP 7.0 __+ 0.8/z M 1.7__+0.36 3 
CGS 19755 3.7 + 0.3/~M 1.4 + 0.22 3 
7-Chlorokynurenic 22.7 + 6.0/tM 1.4 + 0.13 4 
acid 
Kynurenic acid 206 ___ 54/~M 1.9 __. 0.34 4 
CNQX 40 __ 3.2/~M 2.1 +0.2 4 
DNQX 22 __+ 2.6 #M 2.1 -t-0.3 4 
Zinc 88+23/~M 1.2+0.3 3 
Tissue sections were incubated with 5 nM [3H]MK-801 in 
the presence of the appropriate compound for 2 h at 
25°C and rinsed for 80 min in 50mM Tris-acetate 
buffer. Data are presented as mean _+ S.E.M. K~ values 
were calculated from [c~0 values using the Cheng-Prusoff 
equation. 5a 
55 ___ 1.8 nM (mean + S.E.M.) and a Hill coefficient 
(nn) of 0.85 + 0.02 (Fig. 3 and Table 1). Competitive 
NMDA antagonists inhibited [3H]MK-801 binding. 
In SR-CA1, CPP inhibited [3H]MK-801 binding with 
an apparent K~ of 7.0 + 0.8/zM (mean + S.E.M.) and 
n x of 1.7 _ 0.36, while CGS 19755 inhibited binding 
with an apparent Ki of 3.7-1-0.3/zM and n H of 
1.4_ 0.22 (Fig. 4 and Table 1). AP7 (100/zM) and 
AP5 (100/zM) also inhibited [3H]MK-801 binding 
by 80% and 82%, respectively. The inhibition of 
[3H]MK-801 binding by CPP (10/aM) was reversed 
when 100/~ M NMDA was included in the incubation 
mixture. 
[3H]MK-801 binding was also inhibited by glycine 
antagonists (Fig. 5 and Table 1). Of the glycine 
antagonists, 7-chlorokynurenic acid was the most 
potent inhibitor of [3H]MK-801 binding with a Ki of 
22.7 _ 6.0 #M and n H of 1.4 + 0.13, while HA-966 
failed to displace [3H]MK-801 binding in SR-CAI. 
Kynurenic acid inhibited [3H]MK-801 binding with 
a K~ of 206+54/zM and nn of 1.9+0.34. The 
quinoxalinedione compounds, CNQX and DNQX, 
also inhibited [3H]MK-801 binding in SR-CAI with 
K~ values of 40 + 3.2 and 22 + 2.6/~M, respectively 
o°°Z 
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Fig. 4. Inhibition of [3H]MK-801 binding by NMDA 
antagonists in stratum radiatum of the CA1 region of 
hippocampus. Rat brain sections were incubated in 5 nM 
[3H]MK-801 in the presence of varying concentrations of CPP 
or CGS 19755. Each point represents mean specific bind- 
ing + S.E.M. of three animals. The data are representative 
of three separate experiments. 
NSC 40/2--1 
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Fig. 5. Inhibition of [3H]MK-801 binding by glycine 
antagonists in stratum radiatum of the CA1 region of 
hippocampus. Rat brain sections were incubated in 5 nM 
[3H]MK-801 in the presence of varying concentrations of 
7-chlorokynurenic acid or kynurenic acid. Each point 
represents mean specific binding + S.E.M. of four animals. 
The data are representative of four separate experiments. 
(Fig. 6 and Table 1). The Hill numbers for CNQX 
and DNQX were 2.1 + 0.2 and 2.1 + 0.3, respectively. 
CNQX (100#M) reduced [3H]MK-801 binding to 
17% of control; however, the addition of 10#M 
glycine restored [3H]MK-801 binding to 90% of 
control. Similarly, glycine reversed the inhibition of 
[3H]MK-801 binding by DNQX. 
Zinc ions inhibited [3H]MK-801 binding with a K~ 
of  88 + 23#M and nn of 1.2__ 0.3. Tetrahydro- 
aminoacridine (100 #M) inhibited [3H]MK-801 bind- 
ing by 54% while 100 #M dextromethorphan inhibited 
binding by 92% in SR-CA1. When tested at 100 #M, 
(+)PPP and AMPA did not inhibit [3H]MK-801 
binding. 
If 100 #M NMDA was included in the incubation 
mixture following a standard prewash, [3H]MK-801 
binding was enhanced slightly but not significantly 
in SR-CA1. When brain sections were prewashed in 
50 mM Tris-acetate (pH 7.4) for 30 rain at 37°C and 
then incubated with 5 nM [3H]MK-801 for 2 h in the 
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Fig. 6. Inhibition of [3H]MK-801 binding by quinoxaline- 
diones in stratum radiatum of the CAI region of hippo- 
campus. Rat brain sections were incubated in 5nM 
[3H]MK-801 in the presence of varying concentrations of 
CNQX or DNQX. Each point represents mean specific 
binding _+ S.E.M. of four animals. The data are representative 
of four separate experiments. 
presence of 100 pM NMDA, binding in SR-CA l and 
SMDG was significantly enhanced (P < 0.004) by 
181% and 214%, respectively. In a separate exper- 
iment, the effect of glycine stimulation on [3H]MK- 
801 binding in brain sections prewashed at 37C 
was examined. The addition of 100 nM glycine and 
t00pM glycine to the incubation mixture signifi- 
cantly increased [3H]MK-801 binding in the SMDG 
by 214% and 255%, respectively (P <0.05 and 
P < 0.001). 
Regional distribution of  [3H]MK-801 binding sites 
[3H]MK-801 binding in rat brain sections displayed 
regional heterogeneity. The regional distribution of 
[3H]MK-801 binding is summarized in Table 2, in 
terms of both absolute amount of bound [3H]MK-801 
and the amount bound relative to SR-CA1. Repre- 
sentative autoradiographs of [3H]MK-801 binding in 
horizontal sections of two levels in rat brain are shown 
in Fig. 7. 
The amount of [3H]MK-801 binding in the fore- 
brain varied widely. A distinct laminar pattern of 
[3H]MK-801 binding was present in the hippocampal 
formation. Within the hippocampus, the amount of 
binding was greatest in the CA1 region followed by 
CA3 and CA4. SR-CA1 displayed the highest 
amount of [3H]MK-801 binding in the brain. SMDG 
also exhibited high amounts of binding relative to the 
SR-CAI. 
Relatively high amounts of binding were present 
in the medial and lateral olfactory nuclei, primary 
olfactory cortex and external plexiform layer, while 
the internal granule layer of the olfactory tract and 
glomerular layers exhibited the least amount of bind- 
ing. In the cortical areas, the distribution of [3H]MK- 
801 binding varied between regions; however, there 
was more [3H]MK-801 binding to the superficial corti- 
cal layers than to the deep layers. The highest amount 
of [3H]MK-801 binding was present in the cingu~te 
area, whereas the entorhinal region exhibited the least 
binding. Intermediate levels of binding were present 
in the frontoparietal and frontal cortical areas. 
The basal ganglia also exhibited heterogeneous 
[3H]MK-801 binding. Highest amounts of binding 
were present in caudate-putamen and nucleus accum- 
bens, whereas globus pallidus and entopeduncular 
nucleus exhibited lower amounts. Of the basal fore- 
brain structures, the lateral septum displayed the 
highest amount of binding while the binding in the 
ventral limb of the diagonal band and bed nucleus 
of the stria terminalis did not exceed background 
levels. 
Heterogeneous [3H]MK-801 binding was also ob- 
served in the thalamus. Binding in the habenula and 
nucleus reunions did not exceed background levels. 
All other thalamic nuclei displayed moderate amounts 
of binding. 
[3H]MK-801 binding was minimal in brainstem 
structures and cerebellum when the assay was per- 
formed using 5 nM [3H]MK-801. 
[3H]MK-801 binding sites in rat brain 
Table 2. Regional distribution of [3H]MK-801 binding to rat brain sections 
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Brain region 
[3H]MK-801 bound (pmol/mg protein) 
Relative to 
stratum 
Mean radiatum of 
Abbreviation (n = 4) S.E.M. CA1 (%) 
Olfactory region 
Glomerular layer GL 0,058 0.001 5 
External plexiform layer EPL 0.360 0.002 33 
Internal granule layer IGL 0,158 0.017 14 
Medial anterior olfactory nucleus Med AON 0.524 0.041 48 
Lateral anterior olfactory nucleus Lat AON 0.539 0.051 49 
Primary olfactory cortex POC 0.498 0.027 45 
Cortex 
Entorhinal, layers I and II 1,2 ENT 0.341 0.017 31 
Entorhinal, layer IV 4 ENT 0.318 0.016 29 
Entorhinal, layers V and VI 5,6 ENT 0.241 0.006 22 
Frontoparietal, layers I and II 1,2 FrPa 0.608 0.028 55 
Frontoparietal, layer IV 4 FrPa 0.301 0.018 27 
Frontoparietal, layers V and VI 5,6 FrPa 0.192 0.011 17 
Frontal, layers I and II 1,2 FRCX 0.602 0.031 55 
Frontal, layer IV 4 FRCX 0.340 0.016 31 
Frontal, layers V and VI 5,6 FRCX 0.137 0.003 12 
Cingulate, layers I and II 1,2 CICX 0.644 0.033 59 
Cingulate, layers V and VI 5,6 CICX 0.498 0.028 45 
Basal ganglia 
Accumbens nucleus Acb 0.278 0.034 25 
Entopeduncular nucleus EPN 0.006 0.006 l 
Caudate-putamen, medial Med-CPu 0.284 0.011 26 
Caudate-putamen, lateral Lat-CPu 0.227 0.017 21 
Caudate-putamen, anterior Ant-CPu 0.450 0.037 41 
Caudate-putamen, posterior Post-CPu 0.574 0.048 52 
Globus pallidus, anterior Ant-GP 0.038 0.009 3 
Globus pallidus, posterior Post-GP 0.135 0.018 12 
Basal forebrain 
Ventral limb diagonal band VLDB 0.050 0.013 4 
Bed nucleus stria terminalis BNST 0.088 0.016 8 
Lateral septum LS 0.331 0.029 30 
Thalamic nuclei 
Medial dorsal MD-THAL 0.245 0.017 22 
Anterior ventral AV-THAL 0.235 0.019 21 
Ventral lateral VL-THAL 0.220 0.013 20 
Ventral posterior medial VPM-THAL 0.211 0.022 19 
Habenula HB-THAL 0.000 0.000 0 
Lateral geniculate LG 0.266 0.021 24 
Medial geniculate MG 0.250 0.018 23 
Reunions RE 0.030 0.007 3 
Hippocampal formation 
CA1, stratum lacunosum moleculare SLM-CAI 0.614 0.023 56 
CA 1, stratum radiatum SR-CA 1 1.090 0.045 100 
CA l, stratum pyramidale SP-CA l 0.513 0.017 47 
CA1, stratum oriens SO-CA1 0.946 0.041 86 
CA3. stratum radiatum SR-CA3 0.606 0.028 55 
CA3, stratum pyramidale SP-CA3 0.189 0.008 17 
CA3, stratum oriens SO-CA3 0.494 0.034 45 
CA4 CA4 0.199 0.011 18 
Dentate gyrus, stratum moleculare SMDG 0.792 0.028 72 
Brainstem 
Central gray CG 0.000 0.000 0 
Inferior colliculus IC 0.011 0.001 1 
Substantia nigra SNR 0.019 0.01 t 2 
Cerebellum 
Molecular layer Mol-Cb 0.000 0.000 0 
Granule layer Gr-Cb 0.000 0.000 0 
Data represent mean _+ S.E.M. of four animals. Sections were incubated in 5 nM [3H]MK-801 
for 2 h at 25°C and then rinsed for 80 rain in 50 mM Tris-acetate buffer (pH 7.4 at 4°C). 
Quantification of autoradiograms was performed as described in the text. 
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Fig. 7A. 
DISCUSSION 
We have characterized a quantitative autoradio- 
graphic assay of [3H]MK-801 binding to rat brain 
tissue sections. The biochemical characteristics of 
this binding have similarities to those expected for 
membrane receptor binding sites; i.e., a pH optimum 
of approximately 7.4 in Tris-acetate buffer and a 
temperature optimum at 23°C. Although many 
receptor binding sites have a temperature optimum at 
4°C, as discussed below, this ligand has a slow 
association and dissociation with its binding site. 
Such temperature optima have been observed for 
other high affinity ligands such as [3H]spiroperidol 
and [3H]quinuclidinylbcnzilate. 39'~ 
Scatchard analyses of  [3H]MK-801 saturation 
studies indicated a single population of high affinity 
binding sites with a Hill coefficient of  1. Previous 
studies in homogenates, however, have suggested the 
presence of  both high and low affinity [~H]MK-801 
binding sites and [3H]TCP binding sites. 17,u'53 Our 
assay conditions, however, were unfavorable for 
observing a low affinity binding sites because of  the 
long rinse times and the emphasis on MK-801 con- 
centrations below 50 nM in the saturation studies. 
Additional points at higher concentrations of [3H]MK- 
801 and the use of shorter rinse times would be 
necessary to accurately assess a potential low affinity 
site. Interestingly, at 5 nM [~tt]MK-801, no binding 
was observed in the cerebellum; however, at 20 nM 
[3H]MK-801, binding could be observed in the 
cerebellar granule cell layer, suggesting the possibility 
that a low affinity site might exist in this region 
(unpublished observations). 
In homogenate preparations, kin~ic studies of 
[3H]TCP and [3H]MK-801 binding have revealed very 
slow rates of association and dissociation. ~aT,2s These 
kinetic constants are irdtuenced by the concentration 
of glutamate, glycine and divalent cations present 
during the incubation. 4~,45'56 In our studies, [3H]MK- 
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Fig. 7. Autoradiographs of [3H]MK-801 binding to horizontal sections of rat brain (A, dorsal section; B, 
ventral section). Sections were incubated in 5 nM [3H]MK-801. For abbreviations see Table 2. 
801 binding was found to associate very slowly, 
reaching equilibration by 2 h at room temperature. 
Dissociation experiments with tissue sections placed 
in "infinite dilution" and in the absence of added 
glutamate and glycine revealed very slow dissociation 
rates. Both association and dissociation curves fit a 
single site kinetic model. Considerably more data 
points would be necessary, however, to clearly distin- 
guish two sites. Since such detailed studies have 
already been carried out in homogenates, 3~,23,27 it 
did not seem to be productive to repeat them using 
autoradiographic techniques. Calculation of the equi- 
librium dissociation constant, Ka, from the dissoci- 
ation and association rate constants revealed K d values 
less than 1 nM, which did not agree with the Kd values 
calculated from equilibrium saturation studies. The 
association rate constants observed in these exper- 
iments were similar to those observed by Javitt and 
Zukin 23 and Kloog et aL 27 in the presence of  gluta- 
mate and glycine. The dissociation rates observed 
in our studies are considerably slower than those 
observed in the presence of glutamate and glycine 
in homogenate studies and probably reflect the fact 
that the dissociation of [3H]MK-801 and [3H]TCP is 
potently affected by the concentrations of  glutamate 
and glycine in the dissociation buffer. In fact, our 
dissociation rates determined without glutamate or 
glycine in the rinse buffer were similar to those 
determined in homogenate studies in the absence of 
glutamate and glycine. 27 Thus, in routine quantitative 
autoradiography, association rates were fast because 
of  the presence of endogenous glutamate and glycine 
and dissociation rates were slow because of  their 
absence, leading to a calculated Ka = k ~/k + ~ that is 
smaller than the equilibrium Ka. Association rates 
could be determined at several different ligand 
concentrations and the Ka determined directly from 
the data (see Javitt and Zukin23). Alternatively, 
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dissociation experiments in the presence of known 
concentrations of glutamate and glycine could be 
carried out. These experiments are currently being 
carried out in our laboratory. 
The pharmacology of [3H]MK-801 binding in rat 
brain sections is similar to that described in homogen- 
ate binding studies of the PCP site. MK-801 and TCP 
displaced [3H]MK-801 binding with high affinity and 
with Hill coefficients of 1. [3H]MK-801 binding is also 
inhibited by dextromethorphan which has been shown 
to interact with [3H]TCP binding and which has been 
found to attentuate NMDA-induced neurotoxicity in 
cortical cell culturesY 5'48 In contrast, the sigma site 
compound, (+)ppp,31 had no effect on [3H]MK-801 
binding. These data are consistent with the studies 
suggesting [3H]MK-801 is a highly selective ligand for 
the channel associated with the NMDA receptor. 
Tetrahydroaminoacridine, a cholinesterase inhibitor 
reported to displace [3H]TCP binding from rat brain 
membranes I and to selectively reduce NMDA recep- 
tor-mediated toxicity, 12 also inhibited [3H]MK-801 
binding. 
The cation channel associated with the NMDA 
receptor is modulated by glutamate and giycine. 25,42,52 
The presence of both compounds is necessary for 
optimal binding of the ligands to the PCP receptor 
and for optimal activation of the NMDA receptor 
complex as measured physiologically. In extensively 
washed membrane preparations, iigand binding to 
the PCP site is extremely slow. Both glutamate and 
glycine enhance binding of ligands to the PCP site 
and the two amino acids together appear to act syn- 
ergistically. 3'45'~°'5~'56 In Xenopus oocyte preparations, 
glycine has been demonstrated to be necessary for the 
activation of the NMDA receptor complex by gluta- 
mate agonists. 35 Following our standard prewash, 
incubation with exogenously added NMDA or glycine 
did not enhance [3H]MK-801 binding. It is likely that 
the concentrations of glutamate and glycine remaining 
in the tissue sections following a standard prewash 
were sufficient to fully activate the NMDA receptor- 
ion channel complex and permit binding of [3H]MK- 
801. Prewashing the rat brain sections for 30 min at 
37°C did apparently remove substantial amounts of 
endogenous amino acids because under these condi- 
tions [3H]MK-801 binding following a 2-h incubation 
was stimulated significantly with the addition of 
exogenous amino acids. Detailed kinetic experiments 
to address the effects of glutamate and glycine on 
[3H]MK-801 binding were not performed; however, 
glutamate and glycine stimulation of [3H]MK-801 
binding in tissue sections incubated at non-equilibrium 
conditions (a 10-min period) was much greater than 
following a 2-h incubation (data not shown). This 
observation is consistent with a report by Hosford 
et al., 22a which demonstrated that [3H]TCP binding to 
rat brain sections was enhanced by glutamate and 
glycine at non-equilibrium conditions. Glutamate 
and glycine could be stimulating [3H]MK-801 binding 
by increasing the affinity of [3H]MK-801 for its bind- 
ing site ~4~'45 or the presence of these agonists could 
increase the accessibility of [3H]MK-801 to its binding 
site by increasing the channel open time. 3~ Detailed 
kinetic studies using tissue sections that are subjected 
to rigorous prewashing (30min in buffer at 37C) 
would need to be performed to address the mechanism 
by which glutamate and glycine stimulate [3H]MK-801 
binding; however, the anatomical integrity of the 
sections is decreased with excessive prewashing and 
the degree of stimulation of [3H]MK-801 binding is 
variable following such prewashes. Furthermore, 
because of the known regional variation in the endog- 
enous glutamate and glycine concentrations in brain 
it is unlikely that reproducible methods will become 
available soon to adequately remove endogenous 
ligands from tissue sections for autoradiography. 
Thus, homogenate preparations may be more suitable 
for such studies. 
NMDA and glycine antagonists, however, have 
potent effects on [3H]MK-801 binding. The com- 
petitive NMDA antagonists CPP and CGS 19755 
essentially eliminated all [3H]MK-801 binding at 
concentrations of 100 pM. AP5 and AP7 had similar 
effects on [3H]MK-801 binding. NMDA added back 
to the incubation buffer in the presence of CPP 
reversed this inhibition. CPP and CGS 19755 inhibited 
[3H]MK-801 binding in a non-competitive manner; 
therefore only apparent K i values can be calculated. 
Interestingly, the Hill coefficients for CPP and CGS 
19755 inhibition of [3H]MK-801 binding were signifi- 
cantly greater than 1, suggesting, a positive allosteric 
interaction of these compounds with the [3H]MK-801 
binding site. Alternatively, these high Hill coefficients 
could reflect the fact that CPP and CGS 19755 slow 
the association rate of MK-801 binding and may 
therefore raise the apparent Hill coefficient. This effect 
of glutamate and glycine antagonists on association 
rate may also have influenced the calculation of their 
apparent Ki values. The 2-h incubation period used in 
our assay is longer than previously reported auto- 
radiographic studies of [3H]MK-801 binding; 4"5 thus 
the apparent Ki values calculated for the NMDA 
antagonists may appear less potent than K, values ob- 
tained from [3H]MK-801 binding performed at shorter 
incubation periods or directly from NMDA-sensitive 
[3H]glutamate assays. Glycine antagonists kynurenic 
acid and 7-chlorokynurenic acid also potently inhib- 
ited [3H]-MK-801 binding and virtually eliminated 
measurable binding. Glycine reversed this inhibition 
of [3H]MK-801 binding. As with the glutamate antag- 
onists, the Hill coefficients for kynurenic and 7- 
chlorokynurenic acid inhibition of [3H]MK-801 
binding were significantly greater than 1, suggesting 
again a positive allosteric interaction with .he 
[3H]MK-801 binding site. The rank order potency of 
both the NMDA and glycine antagonists are identical 
to those observed in previous homogenate studies? °'49 
In homogenate preparations, HA-966 produced only 
a partial decrease of [3H]MK-801 binding. 9 Interest- 
ingly, in our studies HA-966 did not have any effect 
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on [aH]MK-801 binding to rat brain tissue sections. 
This would be consistent with the recent report by 
Dansyz et al. 9 that suggested that HA-966 modulates 
the N M D A  receptor complex differently than 7- 
chlorokynurenic acid. It is also possible that HA-966 
only acts at a subset of glycine sites that is not 
measured in this assay. 
The non-NMDA receptor agonist, AMPA, 29'3° had 
no effect on [3H]MK-801 binding. The quinoxaline 
derivatives CNQX and DNQX, recently described as 
AMPA receptor antagonists, ~4,22 however, did inhibit 
[3H]MK-801 binding in our autoradiographic assay. 
CNQX and DNQX have been shown in prior studies 
to interact with the glycine site at high concentra- 
tions 2°'26'33 and are likely to inhibit [3H]MK-801 bind- 
ing by interacting with that site. Consistent with this 
notion is the fact that glycine reverses CNQX antagon- 
ism of [3H]MK-801 binding. As with the other NMDA 
and glycine antagonists, the Hill coefficients for 
CNQX and DNQX inhibition for [3H]MK-801 bind- 
ing were greater than 1, suggesting a positive allosteric 
interaction with the [3H]MK-801 site. 
In addition to regulation by glutamate and glycine, 
the N M D A  receptor-ion channel activity appears to 
be modulated by zinc ions. In homogenate studies, 
zinc inhibited [3H]MK-801 binding. 43'~ Further- 
more, NMDA-evoked responses are antagonized by 
zinc. 7.4~.~ At concentrations consistent with these 
physiological and biochemical studies, zinc inhibited 
[3H]MK-801 binding in this assay with a Hill co- 
efficient of  1. 
[3H]MK-801 binding was heterogeneously distri- 
buted throughout the rat brain with the following 
order of binding densities: hippocampal formation > 
cortical areas > striatum > thalamus. Interestingly, 
the brainstem and cerebellum did not reveal [3H]MK- 
801 binding above background levels when assayed 
in the presence of  5 nM [3H]MK-801. As discussed 
above, it is possible that a low affinity binding site in 
these areas may be present but is not detected using 
standard assay conditions. In fact, [3H]TCP binding 
studies in membrane preparations have revealed the 
presence of low affinity PCP binding sites in the cere- 
bellum. 17'18"53 Furthermore, in studies of rat cerebellar 
slices, an allosteric interaction between PCP binding 
sites and N M D A  receptors has been reported. TM 5s.59 
CONCLUSION 
The regional distribution of [3H]MK-801 binding 
sites in rat brain sections reported here is similar to the 
pattern of  N M D A  receptors labeled with [3H]gluta- 
mate or (+)[3H]Cpp.16'3s There is a high degree of 
correlation between the regional binding densities of 
[3H]MK-801 binding and strychnine-insensitive [3H]- 
glycine binding in rat brain sections (S. Y. Sakurai 
and J. W. McDonald, unpublished observations). 
Furthermore, the distribution of [3H]MK-801 binding 
and [3H]TCP binding in rat brain sections is also 
highly correlated (r 2 = 0.96, data taken from Maragos 
et al)4). Thus, the [3H]MK-801 binding to rat brain 
sections described in this paper appears to be labeling 
the NMDA receptor-ion channel complex. 
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